The use of long-acting injectables in early-phase schizophrenia
Lancet Psychiatry
.
2023 Jul;10(7):480.
doi: 10.1016/S2215-0366(23)00141-4.
Authors
Maxwell Zachary Price
1
,
Richard Louis Price
2
Affiliations
1
Hackensack Meridian School of Medicine, Nutley, NJ, USA. Electronic address: maxwell.price@hmhn.org.
2
Weill Cornell Medical College, New York, NY USA.
PMID:
37353254
DOI:
10.1016/S2215-0366(23)00141-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Antipsychotic Agents* / therapeutic use
Humans
Injections
Schizophrenia* / drug therapy
Substances
Antipsychotic Agents